Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults [Rosuvastatina versus sustitucion del Inhibidor de la Proteasa en pacientes adultos con infeccion por el VIH e hipercolesterolemia]

Trial Profile

Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults [Rosuvastatina versus sustitucion del Inhibidor de la Proteasa en pacientes adultos con infeccion por el VIH e hipercolesterolemia]

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Rosuvastatin (Primary) ; Antivirals; Peptide hydrolase inhibitors; Ritonavir
  • Indications HIV infections; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms SoS
  • Most Recent Events

    • 07 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Sep 2013 Planned end date (Mar 2015) added as reported by ClinicalTrials.gov.
    • 09 Sep 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01935674).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top